Hywel Bowden Jones

Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York.

ComplexCare Solutions, Inc. is a holding company that provides healthcare services. It offers face-to-face and telephonic health assessments. The company was founded on April 29, 2010 and is headquartered in New York, NY.

Accriva Diagnostics, Inc. provides point-of-care cardiovascular diagnostics services. It products include avoximeter whole blood oximeter, avoximeter whole blood co-oximeter, data management and connectivity, hemochron response whole blood coagulation system, hemochron signature elite whole blood microcoagulation, inrhythm whole blood system, surgicutt bleeding time, tenderfoot heel incision, tenderlett finger incision device and verifynow system platelet reactivity test. The company is headquartered in San Diego, CA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Vertice Pharma UK Parent Ltd. engages in the activities of a holding company with interest in pharmaceutical industry. The company was founded in 2015 and is headquartered in Berkeley Heights, NJ.

Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Intermediate Ltd. functions as an investment holding company. The company is based in London, UK and was founded in 2015.

Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in London, UK and was founded in 2015.

Part of Warburg Pincus & Company US LLC, Vertice Pharma UK Parent Ltd. is a pharmaceutical company based in London, UK. Founded in 2015, the British company develops, manufactures, and distributes pharmaceutical products.

Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Finance Ltd. functions as an investment holding company. The company is based in London, UK and was founded in 2015.

Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France.